10x Genomics (TXG) Net Cash Flow (QoQ) (2019 - 2026)
Powered by 
Analysis
10x Genomics (TXG) Net Cash Flow (QoQ) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 226.93 Bn | 222.99 Bn | 8.34 Bn |
| 2 | Danaher | 145.94 Bn | 141.60 Bn | 3.61 Bn |
| 3 | Agilent Technologies | 42.55 Bn | 40.79 Bn | 1.04 Bn |
| 4 | Illumina | 32.95 Bn | 31.78 Bn | 770.00 Mn |
| 5 | Revvity | 14.53 Bn | 13.51 Bn | 416.87 Mn |
| 6 | Bio-Techne | 11.31 Bn | 11.04 Bn | 211.39 Mn |
| 7 | Bio-Rad Laboratories | 10.34 Bn | 8.72 Bn | 345.80 Mn |
| 8 | Repligen | 9.46 Bn | 8.44 Bn | 110.04 Mn |
| 9 | Bruker | 8.91 Bn | 8.73 Bn | 416.00 Mn |
| 10 | 10x Genomics | 8.16 Bn | 7.61 Bn | 112.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -25.24% |
| Mar 31, 2026 | -60.23% |
| Dec 31, 2025 | 17.65% |
| Sep 30, 2025 | 72.64% |
| Jun 30, 2025 | -38.29% |
| Mar 31, 2025 | 161.09% |
| Dec 31, 2024 | -396.07% |
| Sep 30, 2024 | -24.40% |
| Jun 30, 2024 | 795.98% |
| Mar 31, 2024 | -107.77% |
| Dec 31, 2023 | 377.41% |
| Sep 30, 2023 | -80.27% |
| Jun 30, 2023 | -107.91% |
| Mar 31, 2023 | 878.08% |
| Dec 31, 2022 | 64.02% |
| Sep 30, 2022 | -5.31% |
| Jun 30, 2022 | 86.18% |
| Mar 31, 2022 | -2,037.44% |
| Dec 31, 2021 | 67.53% |
| Sep 30, 2021 | -937.93% |